Skip to content

Addiction: all studies

Page 259 of 855: studies 2,581 to 2,590 of 8,547, newest first. Back to the addiction overview

Research

USO TERAPÊUTICO DA PSILOCIBINA: REVISÃO INTEGRATIVA

Revista fisio&terapia October 8, 2025 Maurício Pedro Luciano da Costa, Pedro Bruschi Peiretti, Pedro Vinicius Rodrigues Silveira Silva et al.

A resurgence of scientific and clinical interest in psychedelic-assisted therapies, particularly with Psilocybin, has been observed. This paper presents an integrative literature review aiming to identify the scientific contributions, potential benefits, and limitations of the therapeutic use of psilocybin in mental health. The study followed a rigorous protocol. Searches were conducted in the...

Continuity and Uniqueness of Consciousness: Logical Paradoxes and a Hypothesis of Additional Biophysical Degrees of Freedom

October 6, 2025 Kande Lekamalaya Senarath Dayathilake

Consciousness remains one of the most profound unsolved problems in science, particularly regarding the persistence of a unique self across disruption, duplication, or time. Existing frameworks—Global Neuronal Workspace Theory (GNWT), Integrated Information Theory (IIT), and Orchestrated Objective Reduction (Orch-OR)—describe mechanisms of awareness but fail to explain continuity and uniqueness...

DOI: 10.33774/coe-2025-t6pmb (opens in new tab) Full text (opens in new tab) Uniqueness Consciousness Bridging networking Falsifiability +11

Cognitive-Developmental Mechanisms in Hallucinations.

Schizophrenia Bulletin October 6, 2025 Charles Fernyhough, Janna De Boer, Paige E Davis et al. 3 citations

Hallucinations figure prominently in a range of psychiatric disorders but, to date, their developmental origins are not well understood. The aim of the present article is to explore how ideas from mainstream developmental psychology can enhance understanding of how hallucinations develop in different modalities across the lifecourse. Hallucinations vary in their clinical significance depending...

DOI: 10.1093/schbul/sbaf144 (opens in new tab) Full text (opens in new tab) 22q11.2 deletion syndrome Autism Child development Deafness +2

Psychedelic compounds directly excite 5-HT2A layer V medial prefrontal cortex neurons through 5-HT2A Gq activation

Translational Psychiatry October 6, 2025 Gavin P. Schmitz, Yi-Ting Chiu, Mia L. Foglesong et al. 13 citations

Psilocybin, and its active metabolite psilocin, have seen renewed interest due to studies suggesting potential therapeutic utility. 5-Hydroxytryptamine2A receptors (5-HT 2A Rs) are primary mediators of the psychoactive effects of psychedelics in animals and humans, but the underlying neurobiological mechanisms remain poorly understood. Functional magnetic resonance imaging identified...

The psychoactive compound ibogaine sex-dependently alters the firing rate and afterhyperpolarization of Ih-negative neurons in the mouse ventral tegmental area

Neuroscience October 5, 2025 Jannik Nicklas Eliasen, Amir Rezagholizadeh, Helene Påbøl Jacobsen et al. 1 citation

Depression and substance use disorder affect millions world-wide, and risk factors include sex. Conventional pharmacotherapies show at best a 50 % success rate. Psychedelics exhibit both anti-addictive and anti-depressive properties. One of these, ibogaine, a root bark sourced alkaloid, interacts with receptors implicated in anti-depressive and anti-addictive effects with affinities in the...

DOI: 10.1016/j.neuroscience.2025.10.001 (opens in new tab) Afterhyperpolarization Ventral tegmental area Excitatory postsynaptic potential Gabaergic +12

Different realities: Symbolic boundaries and psychedelic drug use

Crime Media Culture An International Journal October 3, 2025 Emily Wagner, Jacob H. Erickson 1 citation

This study examines how psychedelic drug users construct symbolic boundaries to differentiate themselves from other drug users. Drawing on 32 semi-structured interviews with people who have used psychedelic drugs, we explore how participants construct their psychedelic use as distinct from, and superior to, other forms of drug use. Participants differentiate themselves from “hard” drug users in...

Bridging consciousness to our narrative brain: evolutionary insights.

Frontiers in Psychology October 3, 2025 Antonio Benítez-burraco, Francesco Ferretti

There is a long tradition of (attempts at) bridging language and consciousness. Both are human-specific traits, even with precursors in other species, and both are intimately intertwined. Putting it very roughly, human consciousness can be construed, to a large extent, as a sort of inner speech (Morin, 2009; Skipper, 2022). By contrast, the most developed forms of animal consciousness only...

DOI: 10.3389/fpsyg.2025.1691355 (opens in new tab) Full text (opens in new tab) Language Consciousness Prosociality Storytelling +1

Clinical pharmacology of ayahuasca: potential applications and future considerations

Expert Review of Clinical Pharmacology October 3, 2025 Lorena Terene Lopes Guerra, Isabella Caroline Da Silva Dias, Jaime E. C. Hallak et al. 2 citations

Similar to what happens with other psychedelics, there is an ongoing debate on subjective experience contribution to overall therapeutic mechanisms, which can depend on the targeted conditions. There are very few evidences from controlled studies, limiting the conclusions on safety and efficacy. On top of that, ayahuasca highly variable composition posits another challenge, and studies using...

DOI: 10.1080/17512433.2025.2577726 (opens in new tab) Clinical pharmacology Limiting Safety pharmacology Systems pharmacology +5

Effectiveness of a Mindfulness-Based Mobile Intervention for Improving Perinatal Mental Health and Reducing Depression During Pregnancy: Randomized Controlled Trial.

Journal of Medical Internet Research October 2, 2025 Minjung Kim, Jin Young Park, Sehwan Park et al.

Background: Pregnancy is a vulnerable period for women, with an increased risk of mental health issues such as depression and anxiety. The perinatal period is particularly important, as maternal mental health significantly impacts maternal physical health, pregnancy outcomes, postnatal outcomes, and fetal and infant development. Psychotherapeutic interventions for depression are essential,...

DOI: 10.2196/75630 (opens in new tab) Full text (opens in new tab) Depression Humans Pregnancy complications Mental health +6

Naltrexone in the Treatment of Ketamine Use Disorders: A Case Report and Literature Review.

Journal of Addiction Medicine October 2, 2025 Rishi Verma, Tom Colley, Claire Waldock et al. 1 citation

Nonprescribed use of ketamine has increased worldwide due to its hallucinogenic and psychedelic effects. Ketamine use disorders (KUDs) are marked by intense cravings and tolerance, which often trigger relapses and worsen recovery outcomes, defined as sustained ketamine abstinence with reduced cravings, resolved withdrawal symptoms, and improved psychosocial functioning. Currently, there are no...

DOI: 10.1097/adm.0000000000001589 (opens in new tab) Full text (opens in new tab) Ketamine dependence Ketamine desire Naltrexone Substance-related disorders